KLK3 and prostate carcinoma: Overexpression of syndecan, a heparan sulfate proteoglycan, in prostate cancer was significantly associated with established features indicative of worse prognosis such as higher preoperative PSA, higher Gleason score, positive surgical margins, an extraprostatic extension of disease and biochemical disease progression.